#ICYMI a video of our #Pathology Grand Rounds from last week featuring William Kaelin, Jr., MD (KaelinLab) of @HarvardMed & Dana-Farber. Many thanks to Dr. Kaelin. Yale School of Medicine Yale Cancer Center Yale Pathology bit.ly/3LPHp7y

Three Dana-Farber researchers are recipients of the 2023 Outstanding Investigator Award from National Cancer Institute: Jean Zhao, PhD; Kimberly Stegmaier, MD and William G. Kaelin, Jr., MD. Congratulations!

➡️ ms.spr.ly/6019iSuiL

We are excited to open our 2024 seminars this week with two fantastic speakers! We will be hosting 2019 Nobel Laureate Bill Kaelin and Matt Boudreau of the KaelinLab to speak about Screening for Natural Product Degraders.

Belzutifan, a HIF-2α inhibitor, has been approved by the U.S. FDA for the treatment of patients with #kidneycancer previously treated with immune checkpoint inhibitors and anti-angiogenic therapies.

This study was led by a study led by Toni Choueiri, MD.

ms.spr.ly/6019iwggf

It was a fun night celebrating all the group’s hard work this year! Happy holidays everyone 🎄

(Re)emerging Principles for Drug Treatment of Cancer:
#AACRFellows William G. Kaelin will address this topic in a keynote lecture at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics (Oct 11-15, Boston).
bit.ly/3t7b59P
#Targets23 KaelinLab

We are Dana-Farber strong! #MOretreat23 with the best of the best!

Kaelin lab crushing some za on a Friday to celebrate the labs R35!!!!!

Couple pics of the team suited for the Kaelin lab holiday party last weekend!

#Review : Von Hippel–Lindau disease: insights into oxygen sensing, protein degradation, and cancer: jci.org/articles/view/…
by William G. Kaelin Jr. KaelinLab Dana-Farber

Research highlight on the study by William G. Kaelin Jr.’s team providing a rationale for the development of specific #GPR35 agonists for the treatment of #ischemic diseases @Science Dana-Farber nature.com/articles/s4416…

👉rdcu.be/cWm4N

Great profile in Nature Reviews Cancer highlighting recent Cancer Cell publications from Harvard Radiation Oncology Residency Program resident Diana Shi, KaelinLab, Sam McBrayer, Daphne Haas-Kogan, et al. Congratulations! #CCAM Brigham and Women's Hospital Dana-Farber Dana-Farber/Boston Children's🎗️ #GoGold

Super pumped about the new paper in Cancer Cell by Diana D. Shi from the lab of Sam McBrayer Children’s Research Institute at UT Southwestern and KaelinLab! Incredible work!
sciencedirect.com/science/articl…

Diana and Sam!! Latest from the lab! Congrats to all involved! 🔥🔥🔥🔥🔥🔥🔥😛😛😛cell.com/action/showPdf…

forbes.com/sites/markmurp… a good one to read

Newest 🔥🔥from the lab! Out yesterday in science!! The follow up to original findings by Ben olenchock and Javid Moslehi science.org/doi/10.1126/sc…

Good photo from the AACR MBCO workshop. Rockstar Diana Shi and our fearless leader Bill cheesing and chillin

Bill crushing that 10,000 ft altitude #hypoxiainthewild #aspen #bikes